GENE DELIVERY Cell-specific therapy on target

被引：12

作者：

Clarke, Daniel T. W. ^{[1
]}

McMillan, Nigel A. J. ^{[1
]}

机构：

[1] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4125, Australia

来源：

NATURE NANOTECHNOLOGY | 2014年 / 9卷 / 08期

关键词：

TRIAL; SIRNA;

D O I：

10.1038/nnano.2014.155

中图分类号：

TB3 [工程材料学];

学科分类号：

082905 [生物质能源与材料];

摘要：

A polymer–lipid nanoparticle with a low molecular weight can preferentially deliver small interfering RNA to endothelial cells, offering an opportunity to treat many diseases.

引用

页码：568 / 569

页数：2

共 7 条

[1]

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis [J].

Coelho, Teresa ;

Adams, David ;

Silva, Ana ;

Lozeron, Pierre ;

Hawkins, Philip N. ;

Mant, Timothy ;

Perez, Javier ;

Chiesa, Joseph ;

Warrington, Steve ;

Tranter, Elizabeth ;

Munisamy, Malathy ;

Falzone, Rick ;

Harrop, Jamie ;

Cehelsky, Jeffrey ;

Bettencourt, Brian R. ;

Geissler, Mary ;

Butler, James S. ;

Sehgal, Alfica ;

Meyers, Rachel E. ;

Chen, Qingmin ;

Borland, Todd ;

Hutabarat, Renta M. ;

Clausen, Valerie A. ;

Alvarez, Rene ;

Fitzgerald, Kevin ;

Gamba-Vitalo, Christina ;

Nochur, Saraswathy V. ;

Vaishnaw, Akshay K. ;

Sah, Dinah W. Y. ;

Gollob, Jared A. ;

Suhr, Ole B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09) :819-829

[2]

Dahlman JE, 2014, NAT NANOTECHNOL, V9, P648, DOI [10.1038/nnano.2014.84, 10.1038/NNANO.2014.84]

[3]

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial [J].

Fitzgerald, Kevin ;

Frank-Kamenetsky, Maria ;

Shulga-Morskaya, Svetlana ;

Liebow, Abigail ;

Bettencourt, Brian R. ;

Sutherland, Jessica E. ;

Hutabarat, Renta M. ;

Clausen, Valerie A. ;

Karsten, Verena ;

Cehelsky, Jeffrey ;

Nochur, Saraswathy V. ;

Kotelianski, Victor ;

Horton, Jay ;

Mant, Timothy ;

Chiesa, Joseph ;

Ritter, James ;

Munisamy, Malathy ;

Vaishnaw, Akshay K. ;

Gollob, Jared A. ;

Simon, Amy .

LANCET, 2014, 383 (9911) :60-68

[4]

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles [J].

Ganesh, Shanthi ;

Iyer, Arun K. ;

Gattacceca, Florence ;

Morrissey, David V. ;

Amiji, Mansoor M. .

JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) :699-706

[5]

Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]

[6]

Kumar V., 2009, ROBBINS COTRAN PATHO

[7]

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement [J].

Tabernero, Josep ;

Shapiro, Geoffrey I. ;

LoRusso, Patricia M. ;

Cervantes, Andres ;

Schwartz, Gary K. ;

Weiss, Glen J. ;

Paz-Ares, Luis ;

Cho, Daniel C. ;

Infante, Jeffrey R. ;

Alsina, Maria ;

Gounder, Mrinal M. ;

Falzone, Rick ;

Harrop, Jamie ;

White, Amy C. Seila ;

Toudjarska, Iva ;

Bumcrot, David ;

Meyers, Rachel E. ;

Hinkle, Gregory ;

Svrzikapa, Nenad ;

Hutabarat, Renta M. ;

Clausen, Valerie A. ;

Cehelsky, Jeffrey ;

Nochur, Saraswathy V. ;

Gamba-Vitalo, Christina ;

Vaishnaw, Akshay K. ;

Sah, Dinah W. Y. ;

Gollob, Jared A. ;

Burris, Howard A., III .

CANCER DISCOVERY, 2013, 3 (04) :406-417

← 1 →